Theralase(R) Closes $CAN 750,000 Non-Brokered Private Placement - Seite 3

Readers should not unduly rely on these forward- looking statements, which are not a guarantee of future performance. There can be no assurance that forward looking statements will prove to be accurate as such forward looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results or future events to differ materially from the forward-looking statements.

Although the forward-looking statements contained in the press release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements.

All forward-looking statements are made as of the date hereof and are subject to change. Except as required by law, the Company assumes no obligation to update such statements.

For More Information:
1.866.THE.LASE (843-5273)
416.699.LASE (5273)
www.theralase.com

Kristina Hachey, CPA
Chief Financial Officer
[e-mail]

SOURCE: Theralase Technologies Inc.

View the original press release on accesswire.com


The Theralase Technologies Stock at the time of publication of the news with a fall of -0,88 % to 0,113EUR on Tradegate stock exchange (23. April 2024, 22:26 Uhr).